LY2881835

CAS No. 1292290-38-0

LY2881835( —— )

Catalog No. M34327 CAS No. 1292290-38-0

LY2881835 is a potent and selective GPR40 agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 411 In Stock
10MG 562 In Stock
25MG 866 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    LY2881835
  • Note
    Research use only, not for human use.
  • Brief Description
    LY2881835 is a potent and selective GPR40 agonist.
  • Description
    LY2881835 is a potent and selective agonist of G protein-coupled receptor 40 (GPR40). LY2881835 has efficacious and durable dose-dependent reductions in glucose levels along with significant increases in insulin and GLP-1 secretion. LY2881835 has the potential for the research of type 2 diabetes mellitus. LY2881835 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    GPR
  • Recptor
    GPR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1292290-38-0
  • Formula Weight
    491.62
  • Molecular Formula
    C33H33NO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(N1CCC2(C=3C(C=C2)=CC=CC3)CC1)C4=CC=C(COC5=CC=C([C@H](CC(O)=O)C#CC)C=C5)C=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hamdouchi C, et al. The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470). J Med Chem. 2016;59(24):10891-10916.?
molnova catalog
related products
  • Questiomycin A

    Questiomycin A is an antibiotic produced in crème fraiche with antibacterial and anticancer activities. Questiomycin A suppresses expression of GRP78, a cell-protective ER chaperone protein.

  • CAY10471 Racemate

    CAY 10471 is a potent highly selective CRTH2/DP 2 receptor antagonist. CAY10471 binds to the human CRTH2/DP2 DP1 and TP receptors( Ki values of 0.6 1200 and >10000 nMrespectively).

  • ML 145

    ML 145 is a selective and potent antagonist of human GPR35, with no significant activity against GPR35 in any of its immediate rodent homologs.